Cilostazol
Top View
- Neuraxial Or Nerve Procedures
- Management of Antiplatelet Therapy in Patients Undergoing Neuroendovascular Procedures
- Platelet Aggregation Inhibitors
- Pharmacogenomic Associations Tables
- Phosphodiesterase Inhibitors in Acute Lung Injury: What Are the Perspectives?
- Non-Dental Drugs a Dentist Should Know: a Review
- Neutrophil Stunning by Metoprolol Reduces Infarct Size
- Ameliorative Effect of Metformin on Methotrexate-Induced Genotoxicity: an in Vitro Study in Human Cultured Lymphocytes
- Preventive Generics Drug List
- Cilostazol Improves HFD-Induced Hepatic Steatosis by Upregulating
- Theophylline As an Adjunct to Control Malignant Ventricular Arrhythmia
- Cilostazol, a Phosphodiesterase Inhibitor, Prevents No-Reflow and Hemorrhage in Mice with Focal Cerebral Ischemia
- (12) Patent Application Publication (10) Pub. No.: US 2013/0252924 A1 Penninger Et Al
- (Therapeutic Products) Regulations 2015
- Cilostazol, a Phosphodiesterase Inhibitor, Prevents No-Reflow and Hemorrhage in Mice with Focal Cerebral Ischemia
- The Clinical Effects of Cilostazol on Atherosclerotic Vascular Disease
- Randomized Comparison of Cilostazol Vs Ticlopidine for Antiplatelet Therapy After Coronary Stenting
- Optimizing Oral Antiplatelet Therapy in Acute Coronary Syndrome